Exploring the Global Action Plan on Antimicrobial Resistance and Its Impact on Healthcare

global action plan on antimicrobial resistance

Introduction

The Nigerian National action plan on Antimicrobial resistance is an essential step in addressing rising drug-resistant infections. Beyond national efforts, the global action plan on antimicrobial resistance guides countries worldwide, offering strategies to reduce the impact of resistant pathogens on healthcare systems. Understanding its framework helps healthcare providers, policymakers, and public health officials adopt effective interventions.

With the increasing threat of antimicrobial resistance, aligning national policies with global standards ensures better preparedness, surveillance, and infection control.

What Is the Global Action Plan on Antimicrobial Resistance?

The global action plan on antimicrobial resistance is a comprehensive framework developed by the World Health Organization (WHO) to combat antimicrobial resistance (AMR) worldwide. Its primary goals are to:

  • Improve awareness and understanding of AMR
  • Strengthen surveillance and research
  • Reduce infection incidence through effective hygiene and vaccination
  • Optimize the use of antimicrobial medicines
  • Promote sustainable investment in new treatments and tools

By implementing the global AMR action plan, countries like Nigeria can align their national strategies with international standards, ensuring coordinated efforts against AMR.

Key Pillars of the Global Strategy on Antimicrobial Resistance

The global strategy on antimicrobial resistance emphasizes a multi-sectoral approach that integrates human health, animal health, and environmental considerations. Its pillars include:

  1. Surveillance and Monitoring – Collecting accurate data on resistant pathogens in hospitals, communities, and livestock.
  2. Infection Prevention and Control – Implementing hygiene, vaccination, and biosecurity measures to reduce transmission.
  3. Antimicrobial Stewardship – Encouraging responsible prescription and use of antibiotics in human and veterinary medicine.
  4. Research and Innovation – Supporting development of new medicines, vaccines, and diagnostic tools.
  5. Global Cooperation – Promoting cross-border partnerships to share data, best practices, and technical support.

By adopting the global strategy on antimicrobial resistance, nations can strengthen healthcare systems and prevent the spread of resistant infections.

How the Global AMR Action Plan Impacts Healthcare

The global AMR action plan directly influences healthcare in several ways:

AreaImpact
HospitalsEncourages infection control measures, reducing hospital-acquired resistant infections
CliniciansGuides rational antibiotic prescribing and treatment protocols
LaboratoriesImproves diagnostic capacity for early detection of resistant pathogens
Policy MakersProvides evidence-based strategies to allocate resources effectively
Public AwarenessPromotes education on antibiotic misuse and AMR prevention

Through these measures, the global AMR action plan ensures that healthcare systems are better prepared to manage resistant infections efficiently.

Global Cooperation and National Alignment

The effectiveness of the global action plan on antimicrobial resistance depends on collaboration between international organizations, national governments, healthcare providers, and the community.

Nigeria’s alignment with the global AMR action plan allows the country to:

  • Integrate surveillance data into national systems
  • Enhance laboratory networks for accurate diagnostics
  • Strengthen infection prevention protocols in hospitals
  • Educate communities on the dangers of antibiotic misuse

By combining global strategy on antimicrobial resistance principles with national policies, Nigeria can reduce the public health burden of resistant infections.

Conclusion

The global action plan on antimicrobial resistance provides a roadmap for countries to tackle one of the most pressing health challenges of our time. Implementing the global AMR action plan alongside local initiatives ensures that healthcare systems can detect, prevent, and respond to resistant infections efficiently.

For Nigeria, aligning with the global strategy on antimicrobial resistance strengthens national healthcare, improves patient outcomes, and protects public health for generations to come.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.